(2R,3S)-2-((1R)-1-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)ETHOXY)-3-(4'-FLUORO(1,1'-BIPHENYL)-4-YL)MORPHOLINE
UNII 3C3SBK845M
Substance Identification & Data
This profile provides standardized clinical and technical data for (2r,3s)-2-((1r)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4'-fluoro(1,1'-biphenyl)-4-yl)morpholine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3C3SBK845M.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 648425-56-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C26H22F7NO2 KDNCHZSKGPSKMA-ZNZBMKLDSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (2r,3s)-2-((1r)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4'-fluoro(1,1'-biphenyl)-4-yl)morpholine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.